Ergenyl

Ergenyl is a medication containing Sodium Valproate, used for various therapeutic purposes. It is administered intravenously and is manufactured by Sanofi Ab in the EU.

Ergenyl, containing Sodium Valproate, is primarily used for managing certain types of seizures and as a mood stabilizer. It is often prescribed for conditions that require intravenous administration, such as acute seizures or when oral medication is not feasible. The medication works by affecting the central nervous system to help control abnormal brain activity.

Common effects of Ergenyl may include drowsiness, dizziness, and nausea. Some users might experience weight changes or tremors. These effects can vary depending on individual health conditions and other factors.

Ergenyl should be used with caution, especially in individuals with liver or pancreatic conditions. Regular monitoring of liver function may be necessary. It is important to follow the advice of a healthcare professional regarding its use.

Ergenyl may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.